Femasys Inc. (FEMY)
USD 1.08
(-5.26%)
USD 1.08
(-5.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -13.16 Million USD | -25.78% |
| 2022 | -10.48 Million USD | -56.18% |
| 2021 | -6.55 Million USD | -19.37% |
| 2020 | -5.79 Million USD | 42.94% |
| 2019 | -10.16 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.26 Million USD | -35.49% |
| 2024 Q1 | -3.23 Million USD | 24.81% |
| 2023 Q2 | -2.68 Million USD | 1.78% |
| 2023 FY | - USD | -25.78% |
| 2023 Q4 | -4.2 Million USD | -12.56% |
| 2023 Q3 | -3.73 Million USD | -39.11% |
| 2023 Q1 | -2.73 Million USD | -2.42% |
| 2022 Q2 | -2.4 Million USD | 9.16% |
| 2022 Q1 | -2.64 Million USD | -24.66% |
| 2022 Q4 | -2.67 Million USD | 3.1% |
| 2022 FY | - USD | -56.18% |
| 2022 Q3 | -2.75 Million USD | -14.53% |
| 2021 FY | - USD | -19.37% |
| 2021 Q2 | -833.02 Thousand USD | 47.1% |
| 2021 Q4 | -2.12 Million USD | -0.82% |
| 2021 Q3 | -2.1 Million USD | -153.08% |
| 2021 Q1 | -1.57 Million USD | -14.67% |
| 2020 FY | - USD | 42.94% |
| 2020 Q1 | -1.92 Million USD | 0.0% |
| 2020 Q4 | -1.37 Million USD | -5.91% |
| 2020 Q3 | -1.29 Million USD | -7.22% |
| 2020 Q2 | -1.2 Million USD | 37.04% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 71.14% |
| AngioDynamics, Inc. | -14.29 Million USD | 7.855% |
| AtriCure, Inc. | -8.1 Million USD | -62.405% |
| Avinger, Inc. | -16.34 Million USD | 19.433% |
| Azenta, Inc. | 55.15 Million USD | 123.879% |
| BioLife Solutions, Inc. | -45.23 Million USD | 70.889% |
| The Cooper Companies, Inc. | 882.8 Million USD | 101.492% |
| Daxor Corporation | 329.74 Thousand USD | 4093.877% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 0.217% |
| GlucoTrack, Inc. | -7.09 Million USD | -85.72% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 238.728% |
| Hologic, Inc. | 1.29 Billion USD | 101.016% |
| ICU Medical, Inc. | 307.69 Million USD | 104.28% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 100.55% |
| KORU Medical Systems, Inc. | -9.39 Million USD | -40.106% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 126.882% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -100.291% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -100.291% |
| Masimo Corporation | 236.7 Million USD | 105.564% |
| Microbot Medical Inc. | -10.63 Million USD | -23.842% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 183.506% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 105.69% |
| Nephros, Inc. | -1.37 Million USD | -854.997% |
| NovoCure Limited | -175.86 Million USD | 92.512% |
| NEXGEL, Inc. | -2.73 Million USD | -382.396% |
| NEXGEL, Inc. | -2.73 Million USD | -382.396% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 84.775% |
| OraSure Technologies, Inc. | 76.15 Million USD | 117.292% |
| Pro-Dex, Inc. | 8.33 Million USD | 258.039% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 68.916% |
| Predictive Oncology Inc. | -13.18 Million USD | 0.096% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -424.27% |
| QuidelOrtho Corporation | 545.6 Million USD | 102.414% |
| Repligen Corporation | 124.29 Million USD | 110.596% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -4455.361% |
| STAAR Surgical Company | 33.22 Million USD | 139.642% |
| Sharps Technology, Inc. | -8.98 Million USD | -46.646% |
| Utah Medical Products, Inc. | 24.8 Million USD | 153.092% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 105.676% |
| Jin Medical International Ltd. | 3.44 Million USD | 482.511% |